A Technology Whose Use is Indispensable

Ralf Boehling, senior manager Process Development,  Process Screening/Kinetics...
Ralf Boehling, senior manager Process Development, Process Screening/Kinetics Lab, BASF

The existing market situation has already led to a shift in strategy from large quantity chemicals to highly innovative specialties. For many syntheses you can use classical batch vessel. But if you are handling highly toxic, hazardous substances or the syntheses have to run under high pressure, high temperature or the products are thermally unstable, or the syntheses includes a gas phase step, you preferably have to work under continuous flow conditions. So, for BASF there is a need to open these process windows. But one of the major problems to face is that the process development for a contin­uous plant from lab to production plant is not quick enough and causes high development cost. Additionally, it takes a long time for construction and building the technical plant. Especially for small scale plants the cost is prohibitive if building the plant traditionally on site step by step. This, however, severely increases the investment risk for new products because the market needs and price structures cannot be realistically foreseen. Therefore, to shorten the process development time and to reduce cost and time for building small scale continuous plants is a platitude but of course is the key for new innovative processes, reactors and products.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.